The reputably conservative Goldman Sachs added health-insurance coverage of sex reassignment surgery last year. The company said it considers the move part of a push to bring in talented candidates and to build a more diverse workforce. Sex change surgeries cost from $5,000 to $150,000 if they are paid out of pocket and that's before hormone and other drug treatments.
Goldman's plan covers the actual surgery and transgender-related prescription drugs, but it doesn't cover electrolysis and other cosmetic treatments. Other large firms offering some form of coverage for transgender treatments are Bank of America, Deutsche Bank, Wachovia, Microsoft, and General Motors. A spokesperson from New York Association for Gender Rights Advocacy said that coverage of the surgery won't break a company's bank because "of the few transgendered employees there may be at any given company, most don't actually want a surgical sex change."
Goldman Sachs was ranked ninth on Fortune's 100 Best Companies to Work For. Want to get a job there? Get some tips here.